R. Manjunatha Kini
Corporate Officer/Principal bei National University of Singapore
Aktive Positionen von R. Manjunatha Kini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| National University of Singapore | Corporate Officer/Principal | - | - |
Karriereverlauf von R. Manjunatha Kini
Ehemalige bekannte Positionen von R. Manjunatha Kini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Gründer | 01.04.2005 | - |
Statistik
International
| Singapur | 3 |
Operativ
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
- Börse
- Insiders
- R. Manjunatha Kini
- Erfahrung
